Hcr Wealth Advisors Bausch Health Companies Inc. Transaction History

Hcr Wealth Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 04, 2022	SELL	$23.0 - $29.01 $2.95 Million - $3.72 Million	-128,321 Closed	0 $0
Q3 2021 Nov 02, 2021	SELL	$25.04 - $30.06 $87,239 - $104,729	-3,484 Reduced 2.64%	128,321 $3.57 Million
Q2 2021 Jul 21, 2021	BUY	$27.43 - $32.7 $61,552 - $73,378	2,244 Added 1.73%	131,805 $3.87 Million
Q1 2021 May 13, 2021	BUY	$21.37 - $34.38 $2.77 Million - $4.45 Million	129,561 New	129,561 $4.11 Million

256

254M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.37B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Hcr Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Hcr Wealth Advisors with notifications on news.